TECB | VGT | TECB / VGT | |
Gain YTD | 5.770 | 3.170 | 182% |
Net Assets | 461M | 102B | 0% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 21.00 | 15.00 | 140% |
Yield | 0.24 | 0.69 | 35% |
Fund Existence | 5 years | 21 years | - |
TECB | VGT | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 3 days ago83% | 3 days ago81% |
Momentum ODDS (%) | 3 days ago81% | 3 days ago88% |
MACD ODDS (%) | 3 days ago84% | 3 days ago85% |
TrendWeek ODDS (%) | 3 days ago88% | 3 days ago90% |
TrendMonth ODDS (%) | 3 days ago85% | 3 days ago89% |
Advances ODDS (%) | 5 days ago90% | 5 days ago90% |
Declines ODDS (%) | 3 days ago79% | 3 days ago82% |
BollingerBands ODDS (%) | 3 days ago85% | N/A |
Aroon ODDS (%) | 3 days ago88% | 3 days ago87% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PGX | 11.60 | -0.01 | -0.09% |
Invesco Preferred ETF | |||
IUS | 51.94 | -0.15 | -0.29% |
Invesco RAFI™ Strategic US ETF | |||
PXI | 46.39 | -0.28 | -0.60% |
Invesco Dorsey Wright Energy MomentumETF | |||
FBY | 20.15 | -0.25 | -1.23% |
YieldMax META Option Income Strategy ETF | |||
CNCR | 12.57 | -0.23 | -1.80% |
Range Cancer Therapeutics ETF |
A.I.dvisor indicates that over the last year, TECB has been closely correlated with AMZN. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if TECB jumps, then AMZN could also see price increases.
Ticker / NAME | Correlation To TECB | 1D Price Change % | ||
---|---|---|---|---|
TECB | 100% | -0.78% | ||
AMZN - TECB | 72% Closely correlated | -1.65% | ||
MSFT - TECB | 70% Closely correlated | +0.53% | ||
AMD - TECB | 67% Closely correlated | -0.45% | ||
INTU - TECB | 67% Closely correlated | -0.53% | ||
ADSK - TECB | 65% Loosely correlated | -2.69% | ||
More |